D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 77 Citations 27,362 396 World Ranking 794 National Ranking 15
Medicine D-index 79 Citations 28,396 437 World Ranking 12230 National Ranking 428

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Cancer

His main research concerns Internal medicine, Intensive care medicine, Surgery, Aspergillosis and Epidemiology. His work deals with themes such as Bacteremia and Fluconazole, which intersect with Internal medicine. His Intensive care medicine research includes elements of Cancer, Antibiotics, Incidence and Etiology.

Claudio Viscoli has included themes like Invasive fungal disease and Clinical trial in his Cancer study. His biological study spans a wide range of topics, including Amphotericin B and Antibacterial agent. His Aspergillosis research incorporates themes from Mycosis and Aspergillus.

His most cited work include:

  • Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group (3691 citations)
  • ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. (751 citations)
  • Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy (670 citations)

What are the main themes of his work throughout his whole career to date?

Claudio Viscoli spends much of his time researching Internal medicine, Intensive care medicine, Immunology, Surgery and Aspergillosis. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Bacteremia. The Intensive care medicine study combines topics in areas such as Cancer, Antibiotics, Neutropenia and Clinical trial.

His research in Immunology intersects with topics in Acquired immunodeficiency syndrome and Virology. His research related to Mycosis, Retrospective cohort study and Regimen might be considered part of Surgery. His Aspergillosis study deals with Voriconazole intersecting with Fluconazole.

He most often published in these fields:

  • Internal medicine (42.42%)
  • Intensive care medicine (23.31%)
  • Immunology (18.41%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (42.42%)
  • Intensive care medicine (23.31%)
  • Epidemiology (9.09%)

In recent papers he was focusing on the following fields of study:

Claudio Viscoli mostly deals with Internal medicine, Intensive care medicine, Epidemiology, Incidence and Cohort. Many of his studies involve connections with topics such as Gastroenterology and Internal medicine. As a part of the same scientific study, Claudio Viscoli usually deals with the Gastroenterology, concentrating on Aspergillosis and frequently concerns with Mucormycosis and Voriconazole.

His work carried out in the field of Intensive care medicine brings together such families of science as Observational study, Antibiotics, Antibiotic resistance and Targeted therapy. His work in Antibiotic resistance addresses subjects such as Antimicrobial, which are connected to disciplines such as Surgery. His Incidence research is multidisciplinary, incorporating perspectives in Hepatitis C and Population study.

Between 2016 and 2021, his most popular works were:

  • Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline (417 citations)
  • Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (285 citations)
  • ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients (247 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Surgery

The scientist’s investigation covers issues in Internal medicine, Intensive care medicine, Antibiotic resistance, Antibiotics and Bacteremia. His research in Confidence interval, Incidence, Transplantation, Neutropenia and Septic shock are components of Internal medicine. His study in Septic shock is interdisciplinary in nature, drawing from both Epidemiology, Intensive care unit and Anesthesiology.

His Critically ill study in the realm of Intensive care medicine connects with subjects such as Special populations. The concepts of his Bacteremia study are interwoven with issues in Retrospective cohort study, Klebsiella pneumoniae, Combination therapy and Pneumonia. His Surgery research includes themes of Cirrhosis and Staphylococcus aureus.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

Ben De Pauw;Thomas J. Walsh;J. Peter Donnelly;David A. Stevens.
Clinical Infectious Diseases (2008)

4026 Citations

ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

O.A. Cornely;M. Bassetti;T. Calandra;J. Garbino.
Clinical Microbiology and Infection (2012)

1153 Citations

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

J. Peter Donnelly;Sharon C. Chen;Carol A. Kauffman;William J. Steinbach.
Clinical Infectious Diseases (2020)

1098 Citations

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

A. J. Ullmann;J. M. Aguado;S. Arikan-Akdagli;D. W. Denning.
Clinical Microbiology and Infection (2018)

828 Citations

Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy

Mario Tumbarello;Pierluigi Viale;Claudio Viscoli;Enrico Maria Trecarichi.
Clinical Infectious Diseases (2012)

759 Citations

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

B J Kullberg;J D Sobel;M Ruhnke;P G Pappas.
The Lancet (2005)

608 Citations

Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

Brahm H. Segal;Raoul Herbrecht;David A. Stevens;David A. Stevens;Luis Ostrosky-Zeichner.
Clinical Infectious Diseases (2008)

481 Citations

International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP).

Brian T. Tsuji;Jason M. Pogue;Alexandre P. Zavascki;Mical Paul;Mical Paul.
Pharmacotherapy (2019)

472 Citations

Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study

Mario Tumbarello;Enrico Maria Trecarichi;Francesco Giuseppe De Rosa;Maddalena Giannella.
Journal of Antimicrobial Chemotherapy (2015)

469 Citations

European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia.

Diana Averbuch;Christina Orasch;Catherine Cordonnier;David M. Livermore.
Haematologica (2013)

463 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Claudio Viscoli

Oliver A. Cornely

Oliver A. Cornely

University of Cologne

Publications: 180

Matteo Bassetti

Matteo Bassetti

University of Genoa

Publications: 174

Thomas J. Walsh

Thomas J. Walsh

Weill Cornell Medicine

Publications: 133

Monica A. Slavin

Monica A. Slavin

Peter MacCallum Cancer Centre

Publications: 127

Olivier Lortholary

Olivier Lortholary

Université Paris Cité

Publications: 127

Dimitrios P. Kontoyiannis

Dimitrios P. Kontoyiannis

The University of Texas MD Anderson Cancer Center

Publications: 112

Patricia Muñoz

Patricia Muñoz

Hospital General Universitario Gregorio Marañón

Publications: 105

Paul E. Verweij

Paul E. Verweij

Radboud University Nijmegen

Publications: 103

Stéphane Bretagne

Stéphane Bretagne

Université Paris Cité

Publications: 101

Andreas H. Groll

Andreas H. Groll

Boston Children's Hospital

Publications: 86

Jacques F. Meis

Jacques F. Meis

Canisius-Wilhelmina Ziekenhuis

Publications: 85

Emilio Bouza

Emilio Bouza

Hospital General Universitario Gregorio Marañón

Publications: 85

Sharon C.-A. Chen

Sharon C.-A. Chen

University of Sydney

Publications: 83

Livio Pagano

Livio Pagano

Catholic University of the Sacred Heart

Publications: 82

Russell E. Lewis

Russell E. Lewis

University of Bologna

Publications: 82

Raoul Herbrecht

Raoul Herbrecht

University of Strasbourg

Publications: 79

Trending Scientists

Eric M. Leeper

Eric M. Leeper

University of Virginia

Geoffrey B. Rhoads

Geoffrey B. Rhoads

Digimarc (United States)

Rui Wang

Rui Wang

Lanzhou University

K. Syassen

K. Syassen

Max Planck Society

Eliseo Ruiz

Eliseo Ruiz

University of Barcelona

Masaaki Teramoto

Masaaki Teramoto

Kyoto Institute of Technology

Martin Saunders

Martin Saunders

University of Western Australia

Jun Lou

Jun Lou

Rice University

Jianguo Hou

Jianguo Hou

University of Science and Technology of China

Benedikt R. Schmidt

Benedikt R. Schmidt

University of Zurich

Kim T. Scribner

Kim T. Scribner

Michigan State University

Dwayne G. Stupack

Dwayne G. Stupack

University of California, San Diego

Andrei Runov

Andrei Runov

University of California, Los Angeles

Michael R. Lowe

Michael R. Lowe

Drexel University

George L. Bakris

George L. Bakris

University of Chicago

Eiji Saitoh

Eiji Saitoh

University of Tokyo

Something went wrong. Please try again later.